Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

What does the research say about sarcopenia?

Sarcopenia is the age-related loss of muscle strength and mass, with consensus criteria on three continents and an all-cause mortality hazard ratio near 1.6. This page summarises the registered trials and reviews that ma

peptides-pro Editorial

Sarcopenia is the formal term for the age-related loss of skeletal muscle strength and mass; the 2025 Asian Working Group for Sarcopenia (AWGS) criteria are used to classify sarcopenia or possible sarcopenia in several of the trials below [5]. It is a condition, not a compound, and the evidence block for this page does not supply a sequence, formula or molecular weight for it. Sarcopenia has consensus criteria on three continents and an all-cause mortality hazard ratio near 1.6, yet no drug is approved for the primary age-related condition, and agents that reliably enlarge muscle have not improved the strength and gait-speed endpoints that define it [4].

The work centres on the biology of force production in skeletal muscle rather than on a single receptor family: ageing is reported to degrade innervation, metabolic competence, regenerative capacity and one further property that jointly determine force output, each druggable in principle [4].

Research Studies

Sarcopenia screening and postoperative exercise in advanced coxarthrosis

The SARCO-COX study evaluates whether screening for sarcopenia in adults aged 65 years or older with advanced hip osteoarthritis, followed by a structured postoperative exercise programme, improves recovery after total hip replacement compared with standard care [1]. Participants undergo assessments of muscle strength, muscle mass, physical function, pain and quality of life before surgery and during follow-up; blood samples and a small muscle biopsy obtained during the planned surgery are analysed for biomarkers related to muscle health [1]. A total of 150 people are expected to participate [1].

Pre-operative sarcopenia and functional recovery after hip arthroplasty

A single-centre exploratory study at Montpellier University Hospital investigates whether low muscle mass and strength before hip-replacement surgery affect the return to everyday independence in people aged 75 years or older [7]. About 20 volunteers scheduled for surgery because of a recent femoral-neck fracture or severe arthritis that no longer responds to usual care answer brief health questionnaires, attempt simple walking and chair-rise tests if possible, and provide a small blood sample; while already under anaesthesia for the planned operation, the surgical team takes a tiny muscle sample through the same approach [7].

Pulsed electromagnetic field therapy for frailty and sarcopenia in community residents

A clinical study is testing pulsed electromagnetic field therapy for frailty and sarcopenia in elderly community residents [2]. The protocol describes informed consent, in which participants are to fully understand the research purpose, procedure, possible benefits and risks before trial-related activities, and a screening step to determine whether they meet the requirements for participating [2].

HB05P, a pasteurised Akkermansia muciniphila ingredient, and muscle strength

A pilot study evaluates whether HB05P, a health functional food ingredient containing pasteurised Akkermansia muciniphila HB05, improves muscle strength, and evaluates its safety [5]. It is a randomised, double-blind, placebo-controlled, parallel-group, single-centre study in 80 adults aged 50 to under 80 years who meet the 2025 AWGS criteria for sarcopenia or possible sarcopenia, randomly assigned 1:1 to test or control [5]. Participants take one 430 mg hard capsule once daily with water after breakfast for 168 days (24 weeks); the test capsule contains 150 mg of HB05P (3 x 10^10 c) [5].

Strength training combined with algae-derived DHA or fish-derived EPA and DHA

A trial evaluates the effects of 12-week supplementation with algae-derived DHA combined with strength training on muscle strength, neuromuscular parameters, post-exercise inflammation and cognitive functions in healthy adults, compared with fish-derived EPA and DHA combined with strength training, strength training alone, and a control group [6]. Body composition is assessed before the training intervention and after 12 weeks: BMI and body composition — fat mass in kg, body fat percentage, and skeletal muscle mass in kg — are determined using bioimpedance methods (In Body 720, Biospac) [6].

Resistance exercise and nutritional support during immunotherapy for melanoma

A randomised study evaluates whether a six-month programme of structured resistance exercise combined with individualised nutritional support can preserve or improve skeletal muscle mass and muscle quality in adults with stage II to IV malignant melanoma who are starting treatment with immune checkpoint inhibitors [8]. Participants are randomly assigned either to the exercise and nutritional intervention in addition to standard oncology care or to standard oncology care alone; the study aims to obtain complete measurements from at least 40 participants, with assessments at baseline, after 3 months and after 6 months, including magnetic resonance imaging [8].

Malnutrition and metabolic failure in high-potency incretin therapy

A systematic review and meta-analysis synthesised data from 19 randomised trials across the SURMOUNT, STEP, SCALE and OASIS programmes to quantify the nutritional and body composition consequences of high-potency incretin agents in adults with obesity [3]. The review followed PRISMA 2020 guidelines, assessed risk of bias with the Cochrane RoB2 tool, rated certainty of evidence using GRADE, and pooled continuous outcomes using mean differences within a random-effects model [3]. The stated objective was that substantial weight loss was achieved, but the extreme energy deficits induced may obscure underlying nutritional deterioration [3].

Muscle quality as a therapeutic target and trial design framework

A review approaches the translational failure in sarcopenia from the biology rather than the pipeline, noting that no drug is approved for the primary age-related condition and that agents which reliably enlarge muscle have not improved the strength and gait-speed endpoints that define it [4]. It frames ageing as degrading four properties of skeletal muscle that jointly determine force production and are each druggable in principle: innervation, through motor-unit loss and failed compensatory reinnervation; metabolic competence, through declining mitochondrial content and respiratory capacity; regenerative capacity, through satellite-cell dr [4].

Adjacent evidence on muscle outcomes

Several reference-only sources support the wider picture without forming the content of this page. A scoping review reports that coffee is a complex source of bioactive compounds, including caffeine, (poly)phenols, trigonelline and diterpenes, and that although habitual coffee consumption has been associated with metabolic benefits, its relationship with skeletal muscle health remains incompletely understood [9]. A source-verified scoping evidence map and translational review reports that anti-osteoporotic drugs are increasingly discussed as candidate dual bone-muscle therapies in osteosarcopenia, yet clinical claims often conflate biological plausibility, observational signals and randomised efficacy [10]. A 32-week randomised controlled trial and molecular mechanism study reports on resistance training based on precise mechanical load monitoring in patients with primary osteoporosis complicated by [11]. A further report describes Bifidobacterium adolescentis-derived nicotinic acid improving host skeletal muscle mitochondrial function to ameliorate sarcopenia [12].

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician. Nothing here is a recommendation for personal use.

Sources

WhatsApp